SOPHiA GENETICS, global leader in Data-Driven Medicine, announced a $110M Series F round, led by aMoon, a leading health-tech & life sciences venture fund based in Israel, and Hitachi Ventures, a venture arm of Japanese Hitachi Group.
Financial institutions including Credit Suisse and the Pictet group also joined the round alongside other new and existing investors. Balderton originally invested in SOPHiA GENETICS in 2017.